IMMUNITYBIO, INC. Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants
IMMUNITYBIO, INC. (IBRX) reported Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants of $41.86 million for the 12-month period ending 2019-12-31, per its 8-K/A filed 2021-04-22.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants · last filed 2021-04-22
- IMMUNITYBIO, INC. stock and warrants issued during period, value, preferred stock and warrants for the quarter ending 2019-12-31 was $6.71M.
- IMMUNITYBIO, INC. stock and warrants issued during period, value, preferred stock and warrants for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- IMMUNITYBIO, INC. stock and warrants issued during period, value, preferred stock and warrants for the quarter ending 2019-06-30 was $0.00, a 100.00% decline year-over-year.
- IMMUNITYBIO, INC. stock and warrants issued during period, value, preferred stock and warrants for the quarter ending 2019-03-31 was $35.15M, a 152730.43% increase year-over-year.
- IMMUNITYBIO, INC. stock and warrants issued during period, value, preferred stock and warrants for fiscal 2018 was $57.00K, a 6.56% decline from fiscal 2017.
- IMMUNITYBIO, INC. stock and warrants issued during period, value, preferred stock and warrants for fiscal 2017 was $61.00K, a 17.31% increase from fiscal 2016.
- IMMUNITYBIO, INC. stock and warrants issued during period, value, preferred stock and warrants for fiscal 2016 was $52.00K.
| Period end | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 3 month | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 6 month | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 9 month | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 12 month | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 12 month as first filed |
|---|---|---|---|---|---|
| 2019-12-31 | $6.71M derived: 8-K/A 12 month − 10-Q 9 month · filed 2021-04-22 | $6.71M derived: sum of 2 quarters · filed 2021-04-22 | $6.71M derived: sum of 3 quarters · filed 2021-04-22 | $41.86M 8-K/A · filed 2021-04-22 | $35.15M 10-K · filed 2020-03-25 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $35.15M 10-Q · filed 2020-11-09 | $35.15M derived: sum of 4 quarters · filed 2021-03-04 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $35.15M 10-Q · filed 2020-08-07 | $35.15M derived: sum of 3 quarters · filed 2021-03-04 | $35.17M derived: sum of 4 quarters · filed 2021-03-04 | |
| 2019-03-31 | $35.15M 10-Q · filed 2020-05-11 | $35.15M derived: sum of 2 quarters · filed 2021-03-04 | $35.17M derived: sum of 3 quarters · filed 2021-03-04 | $35.19M derived: sum of 4 quarters · filed 2021-03-04 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $22.00K derived: sum of 2 quarters · filed 2021-03-04 | $34.00K derived: sum of 3 quarters · filed 2021-03-04 | $57.00K 10-K · filed 2021-03-04 | |
| 2018-09-30 | $22.00K 10-Q · filed 2019-11-05 | $34.00K derived: sum of 2 quarters · filed 2019-11-05 | $57.00K 10-Q · filed 2019-11-05 | ||
| 2018-06-30 | $12.00K 10-Q · filed 2019-08-06 | $35.00K 10-Q · filed 2019-08-06 | |||
| 2018-03-31 | $23.00K 10-Q · filed 2019-05-08 | ||||
| 2017-12-31 | $61.00K 10-K · filed 2020-03-25 | ||||
| 2016-12-31 | $52.00K 10-K · filed 2019-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |